StockData
Kyntra Bio, Inc. logo

Kyntra Bio, Inc. (KYNB) stock

KYNBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$2.04−1.16 (-36.25%)

Close on Nov 17, 2026Market cap $8.26MP/E 0.0Yield –

Kyntra Bio total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

No total debt figures for Kyntra Bio

Kyntra Bio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Kyntra Bio figures

See a number that looks wrong?